Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)

NCT02720107 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: fingolimod

Sponsor

Novartis Pharmaceuticals